gradual relaxation of coronavirus restrictions is stoking hopes for an economic rebound, with the biotechnology industry riding a wave of expectations in the hunt for an effective COVID-19 treatment." data-reactid="16" type="text">The gradual relaxation of coronavirus restrictions is stoking hopes for an economic rebound, with the biotechnology industry riding a wave of expectations in the hunt…
Share on PinterestIn this Special Feature, we round up the latest findings that might bring us closer to ending the COVID-19 pandemic.Every 2 weeks, Medical News Today rounds up the latest research results that may offer hope among the turmoil that is the COVID-19 pandemic. In our previous Special Feature, we looked at vaccine trials…
The World Health Organization (WHO) is appealing for more funding to accelerate vaccine development for about seven to eight "top" candidates, according to the UN agency's chief Tedros Adhanom Ghebreyesus. More than 80,000 people are now known to have died in the United States from COVID-19, according to Johns Hopkins University. Globally, nearly 285,500 have died. …
You don't have permission to access "http://www.medpagetoday.com/neurology/alzheimersdisease/120668" on this server. Reference #18.2c153b17.1775512948.a208d49 https://errors.edgesuite.net/18.2c153b17.1775512948.a208d49
Millions of Americans are taking GLP-1 agonist medications like Ozempic, Wegovy, and Zepbound to lose weight, treat type 2 diabetes, and manage other chronic health conditions. And while these drugs are generally really effective, they can also bring on some not-so-great side effects, including a big drop in muscle mass for some people. Losing muscle
Four companies control about 80 percent of the U.S. beef market, and there is no reason to believe that any of them are satisfied with their share. Published: April 05, 2026, 8:00 am The USDA’s Food Safety and Inspection Service (FSIS) reported that Listeria monocytogenes was the most frequent cause of outbreaks it investigated during fiscal year